Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
9.03
-0.01 (-0.11%)
At close: Dec 20, 2024, 4:00 PM
8.99
-0.04 (-0.44%)
After-hours: Dec 20, 2024, 4:06 PM EST
Aurinia Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$10.33
Upside
+14.40%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $10 | Buy | Reiterates | $10 | +10.74% | Sep 16, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $10 | Buy | Reiterates | $10 | +10.74% | Sep 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +43.96% | Sep 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +43.96% | Mar 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +10.74% | Feb 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +43.96% | Feb 22, 2024 |
RBC Capital | RBC Capital | Buy Maintains $13 → $8 | Buy | Maintains | $13 → $8 | -11.41% | Feb 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +66.11% | Sep 22, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +66.11% | Aug 7, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +66.11% | Jul 6, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +55.04% | May 3, 2023 |
RBC Capital | RBC Capital | Buy Reiterates $11 | Buy | Reiterates | $11 | +21.82% | Feb 23, 2023 |
RBC Capital | RBC Capital | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +21.82% | Jan 4, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $14 | Strong Buy | Maintains | $26 → $14 | +55.04% | Nov 7, 2022 |
RBC Capital | RBC Capital | Buy Maintains $18 → $10 | Buy | Maintains | $18 → $10 | +10.74% | Nov 4, 2022 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 4, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.